ERBB2 and Fibroadenoma: Furthermore, five antigens, selected because loss of expression decreases survival of human HER2 positive and triple negative breast cancer, are immunogenic in women from fibroadenoma to invasive breast cancer and, as a panel, can predict women with DCIS and IBC.